Telechips Inc. (KOSDAQ:054450)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	185,992	187,468	491,551	150,976	218,770	162,886
Market Cap Growth	-52.79%	-61.86%	225.58%	-30.99%	34.31%	23.10%
Enterprise Value	257,939	249,630	501,576	156,785	230,848	144,235
Last Close Price	12600.00	12700.00	33142.68	10927.30	17014.78	12626.97
PE Ratio	-	-	7.85	3.29	31.11	-
PS Ratio	1.00	1.00	2.57	1.00	1.60	1.62
PB Ratio	0.94	0.93	2.00	0.89	2.06	1.76
P/TBV Ratio	1.39	1.33	2.37	1.10	2.42	1.87
P/FCF Ratio	-	43.30	-	-	-	-
P/OCF Ratio	-	32.62	62.79	-	17.18	-
EV/Sales Ratio	1.38	1.34	2.63	1.04	1.69	1.43
EV/EBITDA Ratio	22.58	16.61	17.33	7.11	12.17	321.92
EV/EBIT Ratio	205.33	51.21	29.90	17.08	28.58	-
EV/FCF Ratio	-86.71	57.66	-	-	-	-
Debt / Equity Ratio	0.63	0.63	0.34	0.46	0.44	0.35
Debt / EBITDA Ratio	10.93	8.42	2.88	3.51	2.47	72.43
Debt / FCF Ratio	-	29.21	-	-	-	-
Asset Turnover	0.50	0.50	0.56	0.58	0.73	0.63
Inventory Turnover	2.96	3.05	3.43	3.21	3.70	3.26
Quick Ratio	0.74	0.83	1.80	0.75	1.31	1.89
Current Ratio	1.20	1.24	2.44	1.17	2.13	2.77
Return on Equity (ROE)	-16.52%	-17.22%	30.12%	33.27%	7.08%	-9.63%
Return on Assets (ROA)	0.21%	0.81%	3.06%	2.22%	2.71%	-3.29%
Return on Capital (ROIC)	0.24%	0.93%	3.64%	2.87%	3.63%	-4.61%
Return on Capital Employed (ROCE)	0.50%	1.80%	5.40%	4.40%	4.90%	-
Earnings Yield	-19.29%	-20.57%	12.74%	30.40%	3.21%	-5.78%
FCF Yield	-1.60%	2.31%	-0.59%	-39.29%	-2.34%	-13.42%
Dividend Yield	0.48%	0.47%	0.60%	1.19%	0.70%	-
Payout Ratio	-	-	2.84%	3.29%	-	-
Buyback Yield / Dilution	0.51%	0.83%	-2.82%	-15.14%	-0.10%	-0.15%
Total Shareholder Return	0.98%	1.30%	-2.21%	-13.94%	0.61%	-0.15%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.